Other
IMILOXAN HCL
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
Imiloxan Hcl is a cosmetic ingredient used in product formulations. Exercise caution due to limited available safety data.
Imiloxan hydrochloride is a selective alpha-2 adrenergic antagonist originally developed for peripheral alpha-2 receptor blocking activity. It has been studied in the context of gastrointestinal motility and mast cell stabilisation but has no established cosmetic use. No EU CosIng entry exists, no SCCS review is available, and no CIR assessment exists. The absence of hazard statements and the pharmacological nature of this compound mean it has no demonstrated safety profile for chronic topical cosmetic application. Its receptor-binding activity suggests potential systemic effects if absorbed through skin.
Known concerns
- No EU cosmetic authorisation
- Pharmacologically active compound — receptor binding agent
- No SCCS or CIR safety assessment available
- No safety data for chronic topical exposure
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find IMILOXAN HCL in your products.
Scan any cosmetic product with LuxSense to see if it contains IMILOXAN HCL and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.